Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Homozygosity for a splice junction mutation in exon 8 of the gene encoding lysosomal acid lipase in a Spanish kindred with cholesterol ester storage disease (CESD)

  • 93 Accesses

  • 32 Citations

Abstract

Deficiency of lysosomal acid lipase is expressed in two distinct recognizable phenotypes. Wolman disease represents the severe early onset form, whereas cholesterol ester storage disease is the more benign late onset type. Previous studies have indicated that compound heterozygosity consisting of a G → A mutation at the 3′ splice junction of exon 8 (E8SJM-allele) together with a null allele of the gene encoding lysosomal acid lipase leads to cholesterol ester storage disease. We have now observed homozygosity for the G → A splice junction mutation in a non-related Spanish kindred with the same disease. As expected, the residual activity of lysosomal acid lipase is higher in this case, suggesting that the E8SJM-allele is associated with low residual acid lipase activity. However, the phenotype of the homozygous propositus is more severe compared with the previously described case, indicating that no direct relationship exists between the genotype or residual LAL activity and the precise cholesterol or triglyceride levels in a given patient. Nevertheless, our findings provide convincing evidence that homozygosity for the E8SJM-allele causes cholesterol ester storage disease to at least the same extent as compound heterozygosity consisting of this allele and a null allele.

This is a preview of subscription content, log in to check access.

References

  1. Ameis D, Brockmann G, Merkel M, Ostlund Jr RE, Coates PM, Yang JY, Cortner JA, Feiman SV, Greten H (1993) Cholesterol ester storage disease due to deletions in the lysosomal acid lipase gene. Circulation (Suppl) 88:1–422

  2. Anderson RA, Sando GN (1991) Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesterol ester hydrolase. J Biol Chem 266:22479–22484

  3. Anderson RA, Byrum RS, Moriguchi Y, Bahrani A (1993a) Molecular characterization of mutations in the lysosomal acid lipase/cholesterol ester hydrolase genes of patients with Wolman/cholesterol ester storage disease. Circulation (Suppl) 88:1423

  4. Anderson RA, Rao N, Byrum RS, Rothshild CB, Bowden DW, Hayworth R, Pettenati M (1993b) In situ localization of the genetic locus encoding the lysosomal acid lipase/cholesterol esterase (LIPA) deficient in Wolman disease to chromosome 10q23.2–q23.3. Genomics 15:245–247

  5. Anderson RA, Byrum RS, Coates PM, Sando GN (1994) Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease. Proc Natl Acad Sci USA 91:2718–2722

  6. Aslanidis C, Klima H, Lackner KJ, Schmitz G (1994) Genomic organization of the human lysosomal acid lipase gene (LIPA). Genomics 20:329–331

  7. Assmann G, Seedorf U (1995) Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease. In: Scriver CR, Beaudet LA, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease, 7th edn. McGraw-Hill. New York, pp 2563–2587

  8. Chou Q, Russell M, Birch DE. Raymond J, Bloch W (1992) Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications. Nucleic Acids Res 20:717–1723

  9. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS (1991) Touchdown PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 19:4008

  10. Goldstein JL, Dana SE, Faust JR, Beaudet AL, Brown MS (1975) Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein: observations in cultured fibroblasts from a patient with cholesteryl ester storage disease. J Biol Chem 250:8487–8495

  11. Gustincich S, Manfioletti G, Sal Del G, Schneider C (1991) A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 11:298–302

  12. Haley NJ, Fowler S, De Duve C (1980) Lysosomal acid cholesterol esterase activity in normal and lipid-laden aortic cells. J Lipid Res 21:961–969

  13. Hultman T, Stahl S, Hornes E, Uhlen M (1989) Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as a solid support. Nucleic Acids Res 17:4937–4946

  14. Klima H, Ullrich K. Aslanidis C, Fehringer P, Lackner KJ, Schmitz G (1994) A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesterol ester storage disease. J Clin Invest 92:2713–2718

  15. Mahadevan S, Tappel AL (1968) Lysosomal lipases of rat liver and kidney. J Bol Chem 243:2849–2854

  16. Maslen CL, Illingworth DR (1993) Molecular genetics of cholesterol ester hydrolase deficiency. Circulation (Suppl) 88:1–424

  17. Meisler M (1972) β-galactosidase from human liver. Methods Enzymol 28:820–839

  18. Seedorf U, Assmann G (1993) Methods for the diagnosis of disturbance in intracellular lipid metabolism. Curr Opin Lipidol 4:444–452

  19. Seedorf U, Skovby F, Nickel V, Christensen NC, Roskoss M, Ose L, Assmann G (1993) A single homozygous missense mutation in the LIPA gene causes cholesteryl ester storage disease. Circulation (Suppl) 88:I-422

Download references

Author information

Additional information

This study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Muntoni, S., Wiebusch, H., Funke, H. et al. Homozygosity for a splice junction mutation in exon 8 of the gene encoding lysosomal acid lipase in a Spanish kindred with cholesterol ester storage disease (CESD). Hum Genet 95, 491–494 (1995). https://doi.org/10.1007/BF00223858

Download citation

Keywords

  • Lipase
  • Triglyceride
  • Lipase Activity
  • Null Allele
  • Splice Junction